Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes

Cell Calcium

Volumn 54, Issue 1, 2013, Pages 17-25

  Milošević, Milena ^a,c   Stenovec, MatjaŽ ^a,b   Kreft, Marko ^a,b,d   Petrušić, Vladimir ^e   Stević, Zorica ^f   Trkov, Saša ^a,b   Andjus, Pavle R ^c   Zorec, Robert ^a,b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Celica Biomedical Sciences Center   (Slovenia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

^e Institute of Virology   (Serbia)

^f CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Amyotrophic lateral sclerosis; Astrocytes; Calcium homeostasis; IgG

Indexed keywords

CALCIUM ION; IMMUNOGLOBULIN G; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; EXCITABILITY; EXTRACELLULAR CALCIUM; FEMALE; FLUORESCENCE; HUMAN; MACROGLIA; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 84878218847     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.03.005     Document Type: Article

References (62)

1. Aebischer J., Moumen A., Sazdovitch V., Seilhean D., Meininger V., Raoul C. Elevated levels of IFNγ and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. European Journal of Neurology 2012, 19:753-759.
2. Haidet-Phillips A.M., Hester M.E., Miranda C.J., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature Biotechnology 2011, 29:824-828.
3. Shibata N., Kakita A., Takahashi H., et al. Increased expression and activation of cytosolic phospholipase A2 in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathologica 2010, 119:345-354.
4. Yamanaka K., Chun S.J., Boillee S., et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience 2008, 11:251-253.
5. Boillee S., Yamanaka K., Lobsiger C.S., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
6. Zhang R., Gascon R., Miller R.G., et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). Journal of Neuroimmunology 2005, 159:215-224.
7. Saleh I.A., Zesiewicz T., Xie Y., et al. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression. Journal of Neuroimmunology 2009, 215:96-101.
8. Garbuzova-Davis S., Saporta S., Haller E., et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2007, 2(11):e1205.
9. Appel S.H., Engelhardt J.I., García J., Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:647-651.
10. Engelhardt J.I., Siklós L., Kömüves L., Smith R.G., Appel S.H. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995, 20:185-199.
11. Andjus P.R., Stević-Marinković Z., Cherubini E. Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture. Journal of Physiology 1997, 504(Pt 1):103-112.
12. Fratantoni S.A., Weisz G., Pardal A.M., Reisin R.C., Uchitel O.D. Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle and Nerve 2000, 23:543-550.
13. 2+ enhancement. Acta Neuropathologica 2004, 107:35-46.
14. Pagani M.R., Reisin R.C., Uchitel O.D. Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals. Journal of Neuroscience 2006, 26:2661-2672.
15. Andjus P.R. Immunoglobulins from amyotrophic lateral sclerosis patients enhance the frequency of glycine-mediated spontaneous inhibitory postsynaptic currents in rat hypoglossal motoneurons. Archives of Biological Science Belgrade 2007, 59:251-255.
16. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
17. Holden C. Neuroscience. Astrocytes secrete substance that kills motor neurons in ALS. Science 2007, 316:353.
18. Rothstein J.D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Advances in Neurology 1995, 68:7-20. discussion 21-27.
19. Tortarolo M., Crossthwaite A.J., Conforti L., et al. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. Journal of Neurochemistry 2004, 88:481-493.
20. Vandenberghe W., Ihle E.C., Patneau D.K., Robberecht W., Brorson J.R. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. Journal of Neuroscience 2000, 20:7158-7166.
21. Vermeiren C., Hemptinne I., Vanhoutte N., Tilleux S., Maloteaux J.M., Hermans E. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. Journal of Neurochemistry 2006, 96:719-731.
22. Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 2010, 47:165-174.
23. Van Damme P., Dewil M., Robberecht W., Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neuro-degenerative Diseases 2005, 2:147-159. (Review).
24. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nature Neuroscience 2007, 10:608-614.
25. Nagai M., Re D.B., Nagata T., et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neuroscience 2007, 10:615-622.
26. Stenovec M., Milošević M., Petrušić V., et al. Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes. Acta Physiologica (Oxford) 2011, 203:457-471.
27. Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000, 1:293-299.
28. Schwartz J.P., Wilson D.J. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 1992, 5:75-80.
29. 2+ signals. Cell Calcium 2000, 28:213-223.
30. Nobile M., Monaldi I., Alloisio S., Cugnoli C., Ferroni S. ATP-induced, sustained calcium signaling in cultured rat cortical astrocytes: evidence for non-capacitative, P2X7-like-mediated calcium entry. FEBS Letters 2003, 538:71-76.
31. 2+ as a signalling route. ASN Neuro 2012, 4(2). 10.1042/AN20110061.
32. 2+ sources for the exocytotic release of glutamate from astrocytes. Biochimica et Biophysica Acta 2011, 1813:984-991.
33. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005, 38:261-272.
34. Dulhunty A.F., Pouliquin P. What we don't know about the structure of ryanodine receptor calcium release channels. Clinical and Experimental Pharmacology and Physiology 2003, 30:713-723.
35. Clapham D.E., Montell C., Schultz G., Julius D. International Union of Pharmacology, International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacological Reviews 2003, 55:591-596.
36. Golovina V.A. Visualization of localized store-operated calcium entry in mouse astrocytes. Close proximity to the endoplasmic reticulum. Journal of Physiology 2005, 564(Pt 3):737-749.
37. Uchitel O.D., Appel S.H., Crawford F., Sczcupak L. Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:7371-7374.
38. Mohamed H.A., Mosier D.R., Zou L.L., et al. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. Journal of Neuroscience Research 2002, 69:110-116.
39. O'Connor S.J., Meng Y.G., Rezaie A.R., Presta L.G. Humanization of an antibody against human protein C and calcium-dependence involving framework residues. Protein Engineering 1998, 11:321-328.
40. Luttrell B.M., Henniker A.J. Reaction coupling of chelation and antigen binding in the calcium ion-dependent antibody binding of cyclic AMP. Journal of Biological Chemistry 1991, 266:21626-21630.
41. Verkhratsky A., Kettenmann H. Calcium signalling in glial cells. Trends in Neurosciences 1996, 19:346-352.
42. 2+ entry in both cultured and in situ mouse astrocytes. European Journal of Neuroscience 2005, 21:1626-1634.
43. Matyash M., Matyash V., Nolte C., Sorrentino V., Kettenmann H. Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB Journal 2002, 16:84-86.
44. Putney J.W. Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here). Cell Calcium 2007, 42:103-110.
45. 2+ entry: roles of Orai, Stim and TRP. Biochimica et Biophysica Acta 2006, 1763:1147-1160.
46. 2+ entry in human astrocytoma U373 MG cells: evidence for involvement of store-operated channels. Journal of Neuroscience Research 2008, 86:3456-3468.
47. 2+ influx in rat cortical astrocytes. Cell Calcium 2012, 52:457-467.
48. 2+ entry in glial cells. Journal of Neuroscience 2003, 23:4737-4745.
49. 2+ dynamics and consequent glutamate release from rat astrocytes. Glia 2008, 56:821-835.
50. Verkhratsky A., Rodríguez J.J., Parpura V. Calcium signalling in astroglia. Molecular and Cellular Endocrinology 2012, 353:45-56.
51. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO Journal 1998, 17:414-422.
52. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225.
53. Piccolo E., Innominato P.F., Mariggio M.A., Maffucci T., Iacobelli S., Falasca M. The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene 2002, 21:6520-6529.
54. 2+ via the phospholipase C beta/IP3 pathway in astrocytes from the dorsal spinal cord. Journal of Neuroscience 1995, 15:2961-2971.
55. Fialová L., Svarcová J., Bartos A., et al. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. Journal of Biological Chemistry 2005, 280:11723-11730.
56. Yamazaki T., Suzuki M., Irie T., Watanabe T., Mikami H., Ono S. Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies. Clinical Neurology and Neurosurgery 2008, 110:722-724.
57. Offen D., Halevi S., Orion D., et al. Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology 1998, 51:1100-1103.
58. Yi F.H., Lautrette C., Vermot-Desroches C., et al. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. Journal of Neuroimmunology 2000, 109:211-220.
59. Fray A.E., Ince P.G., Banner S.J., et al. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. European Journal of Neuroscience 1998, 10:2481-2489.
60. Howland D.S., Liu J., She Y., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1604-1609.
61. Stenovec M., Kreft M., Grilc S., Pangrsic T., Zorec R. EAAT2 density at the astrocyte plasma membrane and Ca(2+)-regulated exocytosis. Molecular Membrane Biology 2008, 25:203-215.
62. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochemistry International 2008, 52:142-154.